Inventor · disambiguated record
Paul Bryan Wren
Also filed as: WREN PAUL BRYAN
3 granted patents·6 pending applications·0 citations·filing 2007–2022
42Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD3GLAXO GROUP LTD2GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 3 LTD2CORSI MAURO1GLAXOSMITHKLINE LLC1
Top patents by PatentIndex Score
9 records- 0150US2023220037A1Novel useGLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 3 LTD·Filed 2022·Application pending·0 cites
- 0245US10336719B21-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jul 2, 2019·0 cites·15 claims
- 0343US7989479B2Use of a p38 kinase inhibitor for treating psychiatric disordersGLAXOSMITHKLINE LLC·Filed 2007·Granted Aug 2, 2011·0 cites·6 claims
- 0442US2024173290A1Novel useGLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 3 LTD·Filed 2022·Application pending·0 cites
- 0536US10106515B21-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 23, 2018·0 cites·12 claims
- 0636US2010144755A1Novel CompoundsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 0736US2010069409A1"novel compounds"GLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 0832US2009318424A1Novel compoundsCORSI MAURO·Filed 2007·Application pending·0 cites
- 0922US2017224679A1Use of CXCR2 Antagonists For The Prevention and/or Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN)GLAXOSMITHKLINE IP DEV LTD·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →